Santral Sinir Sistemi Tüberkülozu
Referanslar
Global tuberculosis report 2025. Geneva, Switzerland, World Health Organization, 2025. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2025 ( Ulaşım tarihi 5 Ağustos 2026)
Thakur K, Das M, Dooley KE, Gupta A. The Global Neurological Burden of Tuberculosis. Semin Neurol. 2018 Apr;38(2):226-237. doi: 10.1055/s-0038-1651500. Epub 2018 May 23. PMID: 29791949.
Dodd PJ, Osman M, Cresswell FV, et al. The global burden of tuberculous meningitis in adults: a modelling study. PLoS Glob Public Health 2021; 1: e0000069.
Halk Sağlığı Genel Müdürlüğü T.C. Sağlık Bakanlığı Tüberküloz Tanı ve Tedavi Rehberi; Avilable from: https://hsgm.saglik.gov.tr/depo/birimler/tuberkulozdb/Dokumanlar/Rehberler/Tuberkuloz_Tani_ve_Tedavi_Rehberi.pdf ( Ulaşım tarihi 2 Ağustos 2026)
Navarro-Flores A, Fernandez-Chinguel JE, Pacheco-Barrios N, Soriano-Moreno DR, Pacheco-Barrios K. Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis. J Neurol. 2022 Jul;269(7):3482-3494. doi: 10.1007/s00415-022-11052-8. Epub 2022 Mar 15. PMID: 35288778; PMCID: PMC8920747.
Garg RK. Tuberculosis of the central nervous system: current concepts in diagnosis and treatment. Curr Opin Neurol. 2025;38(4):406-413. doi: 10.1097/WCO.0000000000001358. Epub 2025 Mar 6. PMID: 40047235.
Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J; British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect. 2009; 59(3): 167-87. doi: 10.1016/j.jinf.2009.06.011. Epub 2009 Jul 4. PMID: 19643501.
Donovan J, Cresswell F, Tucker E et al. A clinical practice guideline for tuberculous meningitis. The Lancet Infectious Diseases, 2025; 26, e96-e111
Muzanyi G, Bark CM. Severe tuberculosis. Med Clin N Am 109 (2025) 641–650 https://doi.org/10.1016/j.mcna.2024.12.001.
Lourens R, Singh G, Arendse T, Thwaites G, Rohlwink U. Tuberculous Meningitis Across the Lifespan. J Infect Dis. 2025 Jun 2;231(5):1101-1111. doi: 10.1093/infdis/jiaf181. PMID: 40197992; PMCID: PMC12128070.
Nguyen L, Pieters J. The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol 2005; 15:269–76.
Davis AG, Rohlwink UK, Proust A, Figaji AA, Wilkinson RJ. The pathogenesis of tuberculous meningitis. J Leukoc Biol 2019; 105:267–80. DOI: 10.1002/JLB.MR0318-102R
Spatola M, Nziza N, Irvine EB, et al. Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection. Brain. 2024;147(9):3247-3260. doi: 10.1093/brain/awae066.
Thwaites G, Caws M, D'Sa A, et al. Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. Journal of Clinical Microbiology, 2008; 46(4), 1363-1368. https://doi.org/10.1128/JCM.02180-07
Donovan, J., Duc Bang, N., Dong, H.K.T. et al. Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial. Nat Med 2026; 32, 849–858. https://doi.org/10.1038/s41591-025-04138-z
Park M, Gupta RK. Central Nervous System Mycobacterium Infection: Tuberculosis and Beyond. Neuroimaging Clin N Am. 2023 Feb;33(1):105-124. doi: 10.1016/j.nic.2022.07.006. PMID: 36404038.
Marais S, Thwaites G, Schoeman J et al.Tuberculous meningitis: a uniform case definition for use in clinical research. The Lancet Infectious Diseases, 2010; 10, 803-812
Kalita J, Misra UK, Singh VK,et al. Inclusion of Mechanical Ventilation in Severity Staging of Tuberculous Meningitis Improves Outcome Prediction. Am J Trop Med Hyg. 2020 Aug;103(2):689-695. doi: 10.4269/ajtmh.20-0077. Epub 2020 May 21. PMID: 32458779; PMCID: PMC7410456.
Donovan J, Cresswell FV, Tucker EW, A clinical practice guideline for tuberculous meningitis. Lancet Infect Dis. 2026;26(2):e96-e111. doi: 10.1016/S1473-3099(25)00364-0.
Qui Y, Tang Y, Yu S, et al. Miliary Tuberculosis: A Comprehensive Review of Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Complications. Infect Drug Resist 2026; 19:616761. https://doi.org/10.2147/IDR.S616761
Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63: e147–95. https://doi.org/10.1093/cid/ciw376
Upton CM, Steele CI, Maartens G,et al. Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB). J Antimicrob Chemother. 2022 May 29;77(6):1720-1724. doi: 10.1093/jac/dkac067. PMID: 35257182; PMCID: PMC9633714.
Davis AG, Wasserman S, Stek C, et al. A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for human immunodeficiency virus-associated tuberculous meningitis: the LASER-TBM trial. Clin Infect Dis 2023; 76: 1412 22.
Cresswell FV, Meya DB, Kagimu E, et al. High-dose oral and intravenous rifampicin for the treatment of tuberculous meningitis in predominantly human immunodeficiency virus (HIV) positive Ugandan adults: a phase II open-label randomized controlled trial. Clin Infect Dis 2021; 73: 876–84.
Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013 Jan;13(1):27-35. doi: 10.1016/S1473-3099(12)70264-5.
Butov D, Feshchenko Y, Kuzhko M, et al. Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection. Tuberc Respir Dis (Seoul). 2020 Jan;83(1):96-103. doi: 10.4046/trd.2019.0021.
Ding J, Thuy Thuong Thuong N, Pham TV, et al. Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis. Clin Pharmacol Ther. 2020;107(4):1023-1033. doi: 10.1002/cpt.1783.
Qui Y, Tang Y, Yu S, et al. Miliary Tuberculosis: A Comprehensive Review of Epidemiology, Clinical Manifestations, Diagnosis, Treatment, and Complications. Infect Drug Resist 2026; 19:616761. https://doi.org/10.2147/IDR.S616761
Donovan J, Phu NH, Thao LTP, et al. Adjunctive dexamethasone for the treatment of HIV-uninfected adults with tuberculous meningitis stratified by Leukotriene A4 hydrolase genotype (LAST ACT): Study protocol for a randomised double blind placebo controlled non-inferiority trial. Wellcome Open Res. 2018 Mar 20; 3:32. doi: 10.12688/wellcomeopenres.14007.1.
Sharma SK, Singla R, Sarda P, et al. Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity. Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576.